FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically to anaesthesiology, resuscitation science and transfusiology, and can be applied for replacement of circular blood as a result heavy blood loss. For this purpose mammal is injected with polymerised haemoglobin. Injection is made in such amount to provide in every certain case blood pressure level higher 60 mm of mercury column.
EFFECT: possibility to prevent irreversible damages of cardiovascular system caused by heavy blood loss.
43 cl, 4 dwg, 5 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| POLYMERISED HAEMOGLOBIN SOLUTIONS WITH LOWERED TETRAMER CONTENT AND METHOD OF PRODUCTION THEREOF | 2004 |
|
RU2337705C2 |
| POLYFUNCTIONAL POLYHEMOGLOBIN-ENZYME COMPLEX | 2010 |
|
RU2432172C1 |
| BLOOD SUBSTITUTE WITH FUNCTION OF OXYGEN TRANSFER, PHARMACEUTICAL COMPOSITION (VERSIONS) | 2008 |
|
RU2361608C1 |
| HAEMOGLOBIN COMPOSITION | 2010 |
|
RU2589254C2 |
| CONJUGATES OF HEMOGLOBIN WITH POLYSACCHARIDE | 1999 |
|
RU2225222C2 |
| BLOOD SUBSTITUTE WITH FUNCTION OF OXYGEN TRANSFER | 2007 |
|
RU2340354C1 |
| USE OF POLYMERIZED HEMOGLOBIN FOR MOBILIZATION OF BLOOD FROM DEPOT IN CASE OF BLOOD LOSS | 2021 |
|
RU2811253C2 |
| METHOD AND DEVICE FOR PRODUCING NONCELLULAR ERYTHROCYTE- SUBSTITUTE | 1997 |
|
RU2203087C2 |
| METHOD FOR PERFORMING HARDWARE PLASMAPHERESIS PROCEDURES WITH CIRCULATING PLASMA VOLUME REPLACEMENT FOR CORRECTING BIOLOGICAL AGE IN HEALTHY PEOPLE 40-55 YEARS OLD | 2022 |
|
RU2788817C1 |
| METHOD FOR DETERMINING HEMOGLOBIN, ERYTHROCYTES, LEUKOCYTES, BLOOD PLATELETS QUANTITY, HEMATOKRIT AND ERYTHROCYTE SEDIMENTATION RATE IN WHOLE BLOOD | 2005 |
|
RU2289133C1 |
